12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

CytoTherapeutics preclinical data

CTII's StemCells California Inc. subsidiary showed the restoration of liver function in mice with liver failure following transplantation of...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >